Merck begins late-stage trial of experimental COVID-19 drug

Merck & Co Inc and partner Ridgeback Biotherapeutics said on Wednesday they had begun enrolling patients in a late-stage trial of their experimental drug molnupiravir for prevention of COVID-19 infection.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day.

Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Reuters /  🏆 2. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Novavax COVID-19 vaccine U.S. trial participants count as fully vaccinated two weeks after dosing -CDCParticipants in Novavax Inc's late-stage COVID-19 vaccine trial can be considered fully vaccinated two weeks after completing their two-dose vaccine regimen, the U.S. Centers for Disease Control and Prevention said on Monday.
Read more »

One Unvaccinated Teacher Infected 26 People With COVID-19—Including 18 KidsThe kids were too young to get vaccinated.
Read more »

Woman hospitalized with COVID-19 returns home to find husband dead of same disease'I can't get that picture out of my mind,' Lisa Steadman said. 'I wish I never would have found him like that.'
Read more »

Dr. Jill Biden shares back to school message for teachers, parents amid COVID-19
Read more »

Australia in vaccine swap pact with Singapore as COVID-19 cases surgeAustralia will receive 500,000 doses of Pfizer's COVID-19 vaccine from Singapore this week, Prime Minister Scott Morrison said on Tuesday, after Canberra agreed a swap deal in a bid to curtail surging coronavirus infections.
Read more »

Covid-19 Delta Variant Pummels China’s Services SectorChina’s services sector suffered an unexpectedly severe blow in August as a wave of infections sparked new lockdowns across the country, sending an official gauge of nonmanufacturing activity into contractionary territory.
Read more »